{"id":"dexamethasone-tropisetron","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone is a corticosteroid that reduces inflammation and immune activation by binding glucocorticoid receptors, while tropisetron is a 5-HT3 receptor antagonist that prevents chemotherapy-induced nausea and vomiting (CINV) by blocking serotonin signaling in the chemoreceptor trigger zone. This combination is used to manage side effects in cancer patients undergoing chemotherapy.","oneSentence":"Dexamethasone suppresses inflammatory and immune responses while tropisetron blocks serotonin receptors to prevent nausea and vomiting.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:15.128Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chemotherapy-induced nausea and vomiting (CINV) prevention in cancer patients"}]},"trialDetails":[{"nctId":"NCT07413809","phase":"PHASE3","title":"Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2025-10-31","conditions":"Multiple Myeloma","enrollment":92},{"nctId":"NCT06952920","phase":"PHASE3","title":"Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2025-08-21","conditions":"Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster","enrollment":388},{"nctId":"NCT04817189","phase":"PHASE4","title":"Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2021-02-01","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":414},{"nctId":"NCT06200168","phase":"PHASE3","title":"Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer","status":"RECRUITING","sponsor":"Jiuda Zhao","startDate":"2024-01-16","conditions":"Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting","enrollment":370},{"nctId":"NCT05242874","phase":"PHASE3","title":"Anti-emetic Prophylaxis With or Without Dexamethasone","status":"COMPLETED","sponsor":"Henan Cancer Hospital","startDate":"2022-02-01","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":442},{"nctId":"NCT01843868","phase":"NA","title":"Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP","status":"WITHDRAWN","sponsor":"Australasian Leukaemia and Lymphoma Group","startDate":"2012-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":""},{"nctId":"NCT06437886","phase":"NA","title":"High-dose Opioid Versus Opioid-sparing Anaesthesia in Cardiac Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2024-04-22","conditions":"Cardiac Surgery Patients","enrollment":80},{"nctId":"NCT05533281","phase":"PHASE4","title":"Efficacy of Three Antiemetics in Preventing Nausea and Vomiting","status":"COMPLETED","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-09-15","conditions":"Nausea and Vomiting","enrollment":200},{"nctId":"NCT05564286","phase":"PHASE3","title":"Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer","status":"COMPLETED","sponsor":"Shantou University Medical College","startDate":"2021-07-01","conditions":"Cervical Cancer, Nasopharyngeal Cancer, Chemotherapy-induced Nausea and Vomiting","enrollment":116},{"nctId":"NCT01298193","phase":"PHASE4","title":"Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.","status":"COMPLETED","sponsor":"Spanish Breast Cancer Research Group","startDate":"2011-05","conditions":"Breast Cancer","enrollment":212},{"nctId":"NCT02909478","phase":"PHASE3","title":"Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2017-09-01","conditions":"Chemotherapy-induced Nausea and Vomiting, Colorectal Cancer","enrollment":315},{"nctId":"NCT03571126","phase":"PHASE4","title":"Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer","status":"UNKNOWN","sponsor":"Zunyi Medical College","startDate":"2019-05-09","conditions":"Chemotherapy-induced Nausea and Vomiting, Lung Cancer","enrollment":156},{"nctId":"NCT02195921","phase":"NA","title":"Acupuncture for Chemotherapy-Induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2015-04","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":160},{"nctId":"NCT02195908","phase":"NA","title":"The Different Effectiveness of Single Acupoint（PC6 or CV12) vs Matching Acupoints(PC6 and CV12) in Chemotherapy-induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2014-08","conditions":"to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting","enrollment":160},{"nctId":"NCT02625181","phase":"NA","title":"Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2016-07","conditions":"Postoperative Nausea and Vomiting","enrollment":27034},{"nctId":"NCT01636947","phase":"PHASE4","title":"A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-12-12","conditions":"Nausea, Vomiting","enrollment":494},{"nctId":"NCT01594749","phase":"PHASE3","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-09-24","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":1015},{"nctId":"NCT03061396","phase":"NA","title":"The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints","status":"UNKNOWN","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2017-02-17","conditions":"Electro-acupuncture, Chemotherapy-induced Nausea and Vomiting","enrollment":208},{"nctId":"NCT02479581","phase":"PHASE2","title":"The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Xiangya Hospital of Central South University","startDate":"2015-07","conditions":"Valvular Heart Disease","enrollment":226},{"nctId":"NCT02576327","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"Jun Zhu","startDate":"2015-10","conditions":"Vomiting","enrollment":130},{"nctId":"NCT02096835","phase":"NA","title":"Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2014-01","conditions":"Postoperative Nausea and Vomiting","enrollment":157},{"nctId":"NCT02478047","phase":"NA","title":"Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting","status":"UNKNOWN","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2015-06","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":240},{"nctId":"NCT01101529","phase":"PHASE2","title":"Treatment of Chemotherapy-induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Uppsala University Hospital","startDate":"2010-05","conditions":"Nausea, Vomiting","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dexamethasone+Tropisetron","genericName":"Dexamethasone+Tropisetron","companyName":"Sun Yat-sen University","companyId":"sun-yat-sen-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone suppresses inflammatory and immune responses while tropisetron blocks serotonin receptors to prevent nausea and vomiting. Used for Chemotherapy-induced nausea and vomiting (CINV) prevention in cancer patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}